Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Moderna completes enrollment of Phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273)

worldpharmanewsOctober 23, 2020

Tag: Moderna , mRNA-1273 , COVID-19 , mRNA vaccine

PharmaSources Customer Service